ChemComm
Communication
which form strong homoternary complexes with CB[8]. A binding
stoichiometry of 2 : 1 Phe–CB[8] was confirmed by three indepen-
dent methods. Nevertheless, the sequences present different
binding features strictly related to their amino acid composition
and conformation in solution, confirming that guest environment
plays a significant role in CB[8] binding. This study suggests that
CB[8] can bind Phe (and likely most if not all of the aromatic
residues) not only located at the N-terminus, but also in many
places along a peptide sequence. Homoternary complexation can
be very useful for further Phe-rich peptide dimerisation studies,
such as Ab that is currently under investigation in our laboratory
and other pathologically related peptides.
Both S.S. and S.T.R. are grateful for funding from the ERC
starting investigator grant ASPiRe (240629) and S.T.R. acknowl-
edges the Cambridge Home and European Scholarship Scheme
and Robert Gardiner memorial scholarship.
Fig. 4 ITC titration of sequence 3 into a CB[8] solution.
Table 1 ITC data for CB[8] ternary complexes of 1–3
References
1 B. K. Kim, H. Kang, K. O. Doh, S. H. Lee, J. W. Park, S. J. Lee and
T. J. Lee, Bioorg. Med. Chem. Lett., 2012, 22, 5415–5418.
2 S. Aggarwal, P. Singh, O. Topaloglu, J. T. Isaacs and S. R. Denmeade,
Cancer Res., 2006, 66, 9171–9177.
3 P. Rajgariah and A. Urbach, J. Inclusion Phenom. Macrocyclic. Chem.,
2008, 62, 251–254.
4 D. T. Dang, H. D. Nguyen, M. Merkx and L. Brunsveld, Angew. Chem.,
Int. Ed., 2013, 52, 2915–2919.
5 H. D. Nguyen, D. T. Dang, J. L. J. van Dongen and L. Brunsveld,
Angew. Chem., Int. Ed., 2010, 49, 895–898.
Ka (MÀ2
)
K
a1/Ka2 DH (kcal molÀ1
)
TDS (kcal molÀ1
)
1
2
3
(3.74 Æ 0.7) Â 1010 15.3
(1.58 Æ 0.3) Â 1013 88.3
À15.3 Æ 0.2
À9.02 Æ 0.6
À20.8 Æ 0.2
À0.88 Æ 0.3
À4.49 Æ 0.9
À2.76 Æ 0.3
(7.68 Æ 2.3) Â 109
2.04
6 S. W. Heo, T. S. Choi, K. M. Park, Y. H. Ko, S. B. Kim, K. Kim and
H. I. Kim, Anal. Chem., 2011, 83, 7916–7923.
7 J. M. Chinai, A. B. Taylor, L. M. Ryno, N. D. Hargreaves, C. A. Morris,
P. J. Hart and A. R. Urbach, J. Am. Chem. Soc., 2011, 133, 8810–8813.
8 J. W. Lee, S. Samal, N. Selvapalam, H.-J. Kim and K. Kim, Acc. Chem.
Res., 2003, 36, 621–630.
9 L. Isaacs, Chem. Commun., 2009, 619–629.
10 E. Masson, X. Ling, R. Joseph, L. Kyeremeh-Mensah and X. Lu,
RSC Adv., 2012, 2, 1213–1247.
11 L. M. Heitmann, A. B. Taylor, P. J. Hart and A. R. Urbach, J. Am.
Chem. Soc., 2006, 128, 12574–12581.
12 F. Biedermann, U. Rauwald, J. M. Zayed and O. A. Scherman, Chem.
Sci., 2011, 2, 279–286.
13 O. D. Monera, T. J. Sereda, N. E. Zhou, C. M. Kay and R. S. Hodges,
J. Pept. Sci., 1995, 1, 319–329.
14 H. Du, R. C. A. Fuh, J. Li, L. A. Corkan and J. S. Lindsey, Photochem.
Photobiol., 1998, 68, 141–142.
1
and H-NMR data suggest an additional secondary interaction
with His. 2 is highly prone to fibre formation and likely under-
goes a conformational adjustment prior to binding CB[8]. The
breaking of the strong p–p interactions that are already present
within the peptide bundle causes quenching of the fluorescence
at 303 nm. Moreover, the significantly higher binding constants
measured for 3 are very likely related to the circular conforma-
tion that it adopts in water and its exposed Phe residue. The
cationic N-terminus and the anionic Glu side chain at the
C-terminus are held in close proximity pushing the Phe side
chain far from the backbone and, therefore, allowing better
interaction with CB[8]. This hypothesis is also supported by
computational energy minimisation of 3 (see ESI†).
15 M. J. Krysmann, V. Castelletto, A. Kelarakis, I. W. Hamley, R. A. Hule
and D. J. Pochan, Biochemistry, 2008, 47, 4597–4605.
16 K. E. Marshall, K. L. Morris, D. Charlton, N. O’Reilly, L. Lewis,
H. Walden and L. C. Serpell, Biochemistry, 2011, 50, 2061–2071.
In conclusion, we have reported three pentapeptide sequences,
differing in charge, hydrophobicity and steric hindrance, all of
c
This journal is The Royal Society of Chemistry 2013
Chem. Commun., 2013, 49, 8779--8781 8781